Notably, the anti-psychotic effects of rolipram and the dependence of these effects on PDE4B are consistent with the association of PDE4B gene disruptions with schizophrenia (Millar et al., 2005, Siuciak et al., 2007, Zhang et al., 2008). Here, PDE4B is linked to schizophrenia.